Intensive blood-pressure lowering in patients with acute cerebral hemorrhage

New England Journal of Medicine

Volumn 375, Issue 11, 2016, Pages 1033-1043

  Qureshi, Adnan I ^a   Palesch, Yuko Y ^b   Barsan, William G ^c   Hanley, Daniel F ^d   Hsu, Chung Y ^f   Martin, Renee L ^b   Moy, Claudia S ^e   Silbergleit, Robert ^c   Steiner, Thorsten ^g   Suarez, Jose I ^h   Toyoda, Kazunori ⁱ   Wang, Yongjun ^k   Yamamoto, Haruko ^j   Yoon, Byung Woo ^l  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ Department of Cerebrovascular Medicine ^*  (United States)

^j NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^k CAPITAL MEDICAL UNIVERSITY   (China)

^l Seoul National University Hospital   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; LABETALOL; NICARDIPINE; URAPIDIL; ANTIHYPERTENSIVE AGENT;

ADULT; ADVERSE DRUG REACTION; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; CEREBRAL HEMORRHAGE; FEMALE; GLASGOW COMA SCALE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NICARDIPINE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84988372340     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1603460     Document Type: Article

References (23)

1. Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563, 704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 2007; 25: 32-8.
2. Qureshi AI. The importance of acute hypertensive response in ICH. Stroke 2013; 44:Suppl 1:S67-9.
3. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intra-cerebral hemorrhage. Stroke 1995; 26: 21-4.
4. Anderson CS, Huang Y, Arima H, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hema-toma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010;41:307-12.
5. Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368: 2355-65.
6. Qureshi AI, Palesch YY. Antihyperten-sive Treatment of Acute Cerebral Hemor-rhage (ATACH) II: design, methods, and rationale. Neurocrit Care 2011; 15: 559-76.
7. Qureshi AI, Palesch YY, Martin R, et al. Interpretation and implementation of Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT II). J Vasc Interv Neurol 2014; 7: 34-40.
8. Qureshi AI, Palesch YY, Martin R, et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage study. Arch Neurol 2010;67:570-6.
9. Arima H, Anderson CS, Wang JG, et al. Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. Hypertension 2010;56:852-8.
10. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hem-orrhage growth: an exploratory analysis. Stroke 2007;38:1072-5.
11. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage: incidence and time course. Stroke 1996; 27:1783-7.
12. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-23.
13. Qureshi A, Palesch Y, ATACH II Investigators. Expansion of recruitment time window in Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II trial. J Vasc Interv Neurol 2012; 5: 6-9.
14. McBee N, Hanley D, Kase C, Lane K, Carhuapoma J. The importance of an independent oversight committee to preserve treatment fidelity, ensure protocol com-pliance, and adjudicate safety endpoints in the ATACH II trial. J Vasc Interv Neurol 2012;5:10-3.
15. Qureshi AI. Intracerebral hemorrhage specific intensity of care quality metrics. Neurocrit Care 2011;14:291-317.
16. The European Stroke Initiative Writing Committee, Writing Committee for the EUSI Executive Committee. Recommendations for the management of intracra-nial haemorrhage-part I: spontaneous intracerebral haemorrhage. Cerebrovasc Dis 2006; 22: 294-316.
17. About EQ-5D. Rotterdam, the Netherlands: EuroQol (http://www.euroqol.org/about-eq-5d.html).
18. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005; 43: 203-20.
19. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-85.
20. Lyden PD, Shuaib A, Lees KR, et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke 2007;38:2262-9.
21. Zahuranec DB, Brown DL, Lisabeth LD, et al. Early care limitations indepen-dently predict mortality after intracerebral hemorrhage. Neurology 2007;68:1651-7.
22. Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Blood pressure variability and clinical outcome in patients with acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2015;24:1493-9.
23. Sykora M, Diedler J, Turcani P, Rupp A, Steiner T. Subacute perihematomal edema in intracerebral hemorrhage is associated with impaired blood pressure regulation. J Neurol Sci 2009; 284: 108-12.